Oss, Netherlands

Willem Frederik Johan Karstens

This inventor holds 9 USPTO granted patents and 3 EPO patents. Top assignees: Merck Sharp + Dohme B.v., N.v. Organon, Merck Sharp + Dohme Corp.. Active years: 2007-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Willem Frederik Johan Karstens. Retrieved from https://idiyas.com/inventor/willem-frederik-johan-karstens

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 48(Granted Patents)


Location History:

  • Oss, NL (2007 - 2015)
  • Berghem, NL (2015 - 2018)

Company Filing History:


Years Active: 2007-2018

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of Willem Frederik Johan Karstens

Introduction

Willem Frederik Johan Karstens is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target RORgammaT-mediated diseases. With a total of nine patents to his name, Karstens has established himself as a key figure in his area of expertise.

Latest Patents

Among his latest patents are the RORgammaT inhibitors, which relate to compounds according to Formula (I) or a pharmaceutically acceptable salt or solvate thereof. These compounds are designed for use in the treatment of RORgammaT-mediated diseases or conditions. The innovative nature of these compounds highlights Karstens' commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Karstens has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme B.V. and N.V. Organon. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research and development.

Collaborations

Some of his notable coworkers include Cornelis Marius Timmers and Mario Van Der Stelt. Their collaborative efforts have further enhanced the impact of Karstens' inventions in the pharmaceutical field.

Conclusion

Willem Frederik Johan Karstens is a distinguished inventor whose work in developing RORgammaT inhibitors has the potential to transform the treatment of various diseases. His contributions to the pharmaceutical industry reflect his dedication to innovation and improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…